Birdwatch Note
2024-11-07 00:05:36 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
この37倍の根拠は下記で原典を見れ、治験で１万人あたり①HPVワクチン群で8.5人の死亡②対照群で7.2人が死亡、③子宮頸がんで人口１万人あたりで死ぬ人数は年0.23人なので①対③で37倍との噂です。 https://x.com/yuko_candida/status/1699607027960717321 この治験記録の詳細は下記10,11p等で見れますがこの治験の対照群はプラセボ群で、①と②には有意差はなく、①や②でワクチンと治験薬と関係があるとみなされた死亡は0です。しかも、①、②の4～3割は外傷である等、非常に雑な噂です。 https://www.womens-health.org.nz/wp-content/uploads/2016/08/Cartwright-seminar-Helen-P-H.pdf#page=10 ２３のランダム化比較試験のメタアナリシスでもHPVワクチン群とプラセボ群の間には死亡率の有意差はありません。 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009069.pub3/full/ja
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1854305349182103596
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1854314221993083057
- noteId - 1854314221993083057
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1730937936672
- tweetId - 1854305349182103596
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- この37倍の根拠は下記で原典を見れ、治験で１万人あたり①HPVワクチン群で8.5人の死亡②対照群で7.2人が死亡、③子宮頸がんで人口１万人あたりで死ぬ人数は年0.23人なので①対③で37倍との噂です。 https://x.com/yuko_candida/status/1699607027960717321 この治験記録の詳細は下記10,11p等で見れますがこの治験の対照群はプラセボ群で、①と②には有意差はなく、①や②でワクチンと治験薬と関係があるとみなされた死亡は0です。しかも、①、②の4～3割は外傷である等、非常に雑な噂です。 https://www.womens-health.org.nz/wp-content/uploads/2016/08/Cartwright-seminar-Helen-P-H.pdf#page=10 ２３のランダム化比較試験のメタアナリシスでもHPVワクチン群とプラセボ群の間には死亡率の有意差はありません。 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009069.pub3/full/ja
Note Ratings
| rated at | rated by | |
| 2024-11-06 19:02:16 -0600 | Rating Details | |
| 2024-11-06 18:56:51 -0600 | Rating Details | |
| 2024-11-06 18:56:21 -0600 | Rating Details | |
| 2024-11-06 18:45:40 -0600 | Rating Details | |
| 2024-11-06 18:29:03 -0600 | Rating Details | |
| 2024-11-06 18:20:32 -0600 | Rating Details | |
| 2024-11-06 18:20:25 -0600 | Rating Details | |
| 2024-11-06 18:20:03 -0600 | Rating Details | |
| 2024-11-07 06:42:17 -0600 | Rating Details | |
| 2024-11-07 02:59:57 -0600 | Rating Details | |
| 2024-11-07 02:37:45 -0600 | Rating Details | |
| 2024-11-07 02:22:02 -0600 | Rating Details | |
| 2024-11-07 02:01:40 -0600 | Rating Details | |
| 2024-11-07 00:24:03 -0600 | Rating Details | |
| 2024-11-06 23:59:01 -0600 | Rating Details | |
| 2024-11-06 23:58:02 -0600 | Rating Details | |
| 2024-11-06 23:55:01 -0600 | Rating Details | |
| 2024-11-06 22:51:42 -0600 | Rating Details | |
| 2024-11-06 22:49:36 -0600 | Rating Details | |
| 2024-11-06 22:47:24 -0600 | Rating Details | |
| 2024-11-06 22:26:23 -0600 | Rating Details | |
| 2024-11-06 22:14:44 -0600 | Rating Details | |
| 2024-11-06 22:05:42 -0600 | Rating Details | |
| 2024-11-06 22:04:46 -0600 | Rating Details | |
| 2024-11-06 21:39:19 -0600 | Rating Details | |
| 2024-11-06 21:29:13 -0600 | Rating Details | |
| 2024-11-06 21:25:09 -0600 | Rating Details | |
| 2024-11-06 21:24:59 -0600 | Rating Details | |
| 2024-11-06 20:41:32 -0600 | Rating Details | |
| 2024-11-06 20:36:02 -0600 | Rating Details | |
| 2024-11-06 20:28:21 -0600 | Rating Details | |
| 2024-11-06 20:24:53 -0600 | Rating Details | |
| 2024-11-06 20:14:49 -0600 | Rating Details | |
| 2024-11-06 20:07:27 -0600 | Rating Details | |
| 2024-11-06 19:44:23 -0600 | Rating Details | |
| 2024-11-06 19:38:05 -0600 | Rating Details | |
| 2024-11-06 19:30:05 -0600 | Rating Details | |
| 2024-11-06 19:24:51 -0600 | Rating Details | |
| 2024-11-06 19:23:42 -0600 | Rating Details | |
| 2024-11-06 19:12:43 -0600 | Rating Details | |
| 2024-11-06 18:59:11 -0600 | Rating Details | |
| 2024-11-06 18:55:21 -0600 | Rating Details | |
| 2024-11-06 18:55:18 -0600 | Rating Details | |
| 2024-11-06 18:32:47 -0600 | Rating Details | |
| 2024-11-06 18:21:55 -0600 | Rating Details | |
| 2024-11-06 18:06:09 -0600 | Rating Details | |
| 2024-11-07 00:25:27 -0600 | Rating Details | |
| 2024-11-06 22:11:15 -0600 | Rating Details | |
| 2024-11-06 22:09:14 -0600 | Rating Details | |
| 2024-11-06 21:51:22 -0600 | Rating Details | |
| 2024-11-06 20:42:55 -0600 | Rating Details | |
| 2024-11-06 19:54:05 -0600 | Rating Details | |
| 2024-11-06 19:46:57 -0600 | Rating Details | |
| 2024-11-06 19:33:02 -0600 | Rating Details | |
| 2024-11-06 19:14:57 -0600 | Rating Details | |
| 2024-11-06 19:01:01 -0600 | Rating Details | |
| 2024-11-06 18:54:05 -0600 | Rating Details | |
| 2024-11-06 18:08:13 -0600 | Rating Details |